Commercial Research Funding Opportunity
Forecasted
The National Multiple Sclerosis Society’s Commercial Research Funding Opportunity supports innovative research to develop new MS therapies and diagnostics, bridging discovery and commercial development.
Funder: National Multiple Sclerosis Society
Due Dates (Anticipated): January 2027 (pre-applications) | January 2027 (full applications)
Funding Amounts: Up to $800,000 direct costs per project; typical duration 1–2 years
Summary: Supports development of innovative therapies and diagnostics for multiple sclerosis, bridging early discovery and commercial development.
Key Information: A pre-application is required; program is open to both commercial and select nonprofit institutions globally.
Description
The National Multiple Sclerosis Society, through its Fast Forward program, offers this funding opportunity to accelerate the development of innovative therapies and diagnostic strategies for multiple sclerosis (MS). The initiative aims to bridge the gap between promising scientific discoveries and commercial development, ultimately advancing the Society’s mission to cure MS and improve the lives of those affected by the disease. Funding is guided by the Pathways to Cures Research Roadmap, and requests for applications are periodically released to target research priorities and unmet needs within the MS community.
